NICE Guidance - December 2016
The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of December 2016. This month there are two guidelines and one technology appraisal that impact upon primary care.
The HIV testing guideline covers how to increase the uptake of HIV testing in primary and secondary care, specialist sexual health services and the community. It describes how to plan and deliver services that are tailored to the local prevalence of HIV, promote awareness of HIV testing and increase opportunities to offer testing to people who may have undiagnosed HIV.
The End of life care for infants, children and young people with life-limiting conditions guideline covers the planning and management of end of life and palliative care in for infants, children and young people (aged 0–17 years) with life-limiting conditions. It aims to involve children, young people and their families in decisions about their care, and improve the support that is available to them throughout their lives.
The Ticagrelor for preventing atherothrombotic events after myocardial infarction technology appraisal recommends this treatment as an option for preventing atherothrombotic events in adults who had a myocardial infarction and who are at high risk of a further event. Treatment should be stopped when clinically indicated or at a maximum of 3 years.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « Drug Safety Update - December 2016 | CKS Updates - December 2016 » |
Leave a Comment